1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Sirona

Anonymous board for Sirona


Sort By:
Title ↓
Replies Views
Last Message
  1. anonymous
    Replies:
    21
    Views:
    8,589
  2. anonymous
    Replies:
    9
    Views:
    3,347
  3. Anonymous
    Replies:
    2
    Views:
    9,883

Thread Display Options

Loading...